Tuesday, August 9, 2016
Shionogi has joined the Cambridge Therapeutics Consortium. Launched in July 2015, the consortium links the intellectual know-how of several world renowned academic institutions with the drug developing potential of the pharmaceutical industry.
Johnson & Johnson Innovation, London, has formed a network of partnering offices across U.K. life science clusters. The offices function as extensions of its London Innovation Center, to work with academics and entrepreneurs throughout the U.K. to identify early stage innovation and support the translation of research into new products for patients.